FP7 logo euThe SATURN project has received funding from the European Community's Seventh Framework Programme [FP7/2007-2013] under grant agreement n°241796

Impact of Specific Antibiotic Therapies on the Prevalence of Human Host Resistant Bacteria

Partners: Assistance Publique - Hôpitaux de Paris – (AP-HP)

The organisation

APHPThe Assistance Publique - Hôpitaux de Paris (APHP) is the public hospital system of the city of Paris and its suburbs. Providing healthcare, teaching, research, prevention, education and emergency medical service in 52 branches of medicine, it employs more than 90 000 people (practitioners and administratives) in 44 hospitals. The APHP is linked with the Univerrsity of Paris and its seven colleges of medicine, two of odontology and two of pharmacy. It is the largest hospital system in Europe.

Key staff involved in the project

Laurent GutmannLaurent Gutmann, Professor heads the Laboratories of microbiology at HPSJ and Georges Pompidou Hospital. He is professor in microbiology at Paris Descartes University and was for two years researcher at the Rockefeller Institute in the laboratory of Alexander Tomasz where he worked on the targets of beta-lactams and the cell wall of S. pyogenes. Since then he published more than 140 full papers in peer-reviewed scientific journals. The main area of research was on AMR including resistance to the cell wall antibiotics and fluoroquinolones. He also heads the French Reference Center for Steptococcus pneumoniae. He was the coordinator of a STREP in FP6 (COBRA; combating resistance by broadening the knowledge on molecular mechanism behind resistance  to cell wall antibiotics) and has obtained multiple grants on AMR as part of the INSERM unit 872 where he is one of the senior researchers.

Marie Dominique KitzMarie Dominique Kitz is a senior assistant has expertise in medical microbiology, resistance to antibiotics and in pharmacokinetics of antibiotics. She has published more than 70 full papers in peer-reviewed scientific journals and contributed micobiological and antibiotic expertise for many clinical studies.

Further information


Top ^